Is this you? Create Your Porfile
Avatar

Pedro S. Barradas

Hospital Pulido Valente

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Pedro S. Barradas is active.

Explore More

Publication

Featured researches published by Pedro S. Barradas.

Lung Cancer | 2000

Preliminary results of a randomised phase III trial comparing four cisplatin (P)-based regimens in the treatment of locally advanced and metastatic non-small cell lung cancer (NSCLC)

A Costa; Pedro S. Barradas; Margarida Cristóvão; P Alves; Maria José Melo

Journal of Thoracic Oncology | 2007

P2-248: What is the standard platinium-derivative based-chemotherapy for advanced or metastatic NSCLC: a 10-years trial comparing cisplatin (C) and carboplatin (Ca) in combination with gemcitabine (G)

Susana Clemente; Pedro S. Barradas; Paula Alves; Margarida Cristóvão; Agostinho Costa; Maria José Melo

Lung Cancer | 2003

P-526 Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinum-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective study

Pedro S. Barradas; Maria José Melo; Margarida Cristóvão; Agostinho Costa; Ana P. Alves

Journal of Thoracic Oncology | 2007

P2-064: The impact on survival of high baseline Cyfra 21-1 in non-small-cell-lung cancer (NSCLC) submitted to surgery: a 15-years study including 829 patients (pts). The role of adjuvant and neo-adjuvant chemotherapy

Pedro S. Barradas; Maria José Melo; Agostinho Costa; Paula Alves; Margarida Cristóvão

Journal of Thoracic Oncology | 2007

P2-065: Value of Cyfra 21-1 (C21) as determinant of survival, predictor of disease course and asssistant of therapeutic decisions in non-small-cell lung cancer (NSCLC) patients (pts): a large 15-year study.

Pedro S. Barradas; Margarida Cristóvão; Agostinho Costa; Paula Alves; Maria José Melo

Revista Portuguesa De Pneumologia | 2003

C18. Docetaxel como quimioterapia de 2ª linha nos doentes com CPNPC: estudo prospectivo multicêntrico.

Ana Sofia Oliveira; Pedro S. Barradas; Agostinho Costa; Ana Figueiredo; A.P. Alves; Margarida Cristóvão; Fernando Barata; Maria José Melo

Lung Cancer | 2003

35 Second line chemotherapy with cisplatin (C) plus paclitaxel (P) for chemo refractory and resistant small cell lung cancer (SCLC) patients (pts)

Pedro S. Barradas; Adelia M. Lopes; A Costa; Margarida Cristóvão; Ana P. Alves; Maria-Jose S. Melo

Lung Cancer | 2003

P-7 Docetaxel as second-line chemotherapy (CT) in advanced non small cell lung cancer(NSCLC) patients (pts): does it really work?

Pedro S. Barradas; Ana S. Oliveira; Agostino S. Costa; Ana Figueiredo; Ana P. Alves; Margarida Cristóvão; Fernando Barata; Maria-Jose S. Melo

Lung Cancer | 2003

P-11 Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinium-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A retrospective study with 396 patients (pts)

Pedro S. Barradas; Maria; Jose S. Melo; Margarida Cristóvão; A Costa; Ana P. Alves

Lung Cancer | 2000

Value of Cyfra 21-1 (CY21) as determinant of survival and predictor of disease course in lung cancer (LC) patients (pts)

Pedro S. Barradas; Margarida Cristóvão; A Costa; A.L Fragoso; P Alves; Maria José Melo

Explore More

Collaboration

Dive into the Pedro S. Barradas's collaboration.

Top Co-Authors
Avatar

Margarida Cristóvão

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Maria José Melo

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Agostinho Costa

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Paula Alves

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Ana Figueiredo

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Fernando Barata

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

A.P. Alves

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Ana Sofia Oliveira

Hospital Pulido Valente

View shared research outputs
Top Co-Authors
Avatar

Susana Clemente

Hospital Pulido Valente

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge